Phathom Pharmaceuticals, Inc. (PHAT) Earnings
|
Expand Research on PHAT
| Next EPS Date | 8/6/26 | EPS Growth Rate | +74.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +48.9% | Revenue Growth Rate | +88.1% |
| Average % Move 1-Wk after EPS | +4.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.20 | N/A | N/A | $74.3M | = | N/A | N/A | ||
| 4/30/26 | Q126 | -$0.18 | -$0.27 | +$0.09 | $58.3M | $58.67M | = |  | | Details | |
| 2/26/26 | Q425 | -$0.08 | -$0.42 | +$0.34 | $57.6M | $56.8M | = | | | Details | |
| 10/30/25 | Q325 | -$0.15 | -$0.47 | +$0.32 | $49.5M | $47.03M | = | | | Details | |
| 8/7/25 | Q225 | -$0.79 | -$0.91 | +$0.12 | $39.5M | $36.38M | = | | | Details | |
| 5/1/25 | Q125 | -$1.07 | -$1.11 | +$0.04 | $28.5M | $27.75M | = | | | Details | |
| 3/6/25 | Q424 | -$0.79 | -$1.21 | +$0.42 | $29.7M | $26.04M | = | | | Details | |
| 11/7/24 | Q324 | -$1.32 | -$1.47 | +$0.15 | $16.4M | $12.61M | N/A | | | Details |
